Drug profile · INN
chikungunya vaccine (live)
IXCHIQ
chikungunya vaccine (live) (IXCHIQ) is a biological vaccine - induces immune response.
EMA: approved Antiinfectives for systemic use (J07) J07BP01
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — chikungunya vaccine (live)
- Class
- Antiinfectives for systemic use (J07)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
chikungunya vaccine (live) (IXCHIQ) is a biological vaccine - induces immune response.
Key facts
INN chikungunya vaccine (live)
Brand IXCHIQ
Mechanism Biological vaccine - induces immune response
Therapeutic class Antiinfectives for systemic use (J07)
ATC code J07BP01
Mechanism of action
Biological vaccine - induces immune response
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is chikungunya vaccine (live)?
chikungunya vaccine (live) (IXCHIQ) is a biological vaccine - induces immune response.
What is the brand name for chikungunya vaccine (live)?
IXCHIQ is a marketed brand name for chikungunya vaccine (live). Check FDA Drugs@FDA for the current US label holder and prescribing information.